Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Higgins

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|April 2, 2016
Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1Mostafa M Ghorab, Mansour S Alsaid, Marwa G El-Gazzar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 23, 2016
NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 4-aminoquinazoline derivativesMostafa M Ghorab, Mansour S Alsaid, Marwa G El-Gazzar, et al.
Scientific Reports|August 13, 2025
A fluorescence lifetime-based FLIM-timer for measuring the protein turnover of transcription factor Nrf2 in live cellsDina Dikovskaya, Claudia Bento-Pereira, Kanade Shiga, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 8, 2016
Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivativesMostafa M Ghorab, Mansour S Alsaid, Maureen Higgins, et al.
Ebiomedicine|May 17, 2021
Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinomaKevin Roth, Louis Coussement, Elena V Knatko, et al.
Drug Design, Development and Therapy|August 20, 2016
NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivativesMostafa M Ghorab, Mansour S Alsaid, Maureen Higgins, et al.
Molecular Cancer Therapeutics|February 19, 2013
Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 9, 2014
Synthesis of (13) C2 (15) N2 -labeled anti-inflammatory and cytoprotective tricyclic bis(cyanoenone) ([(13) C2 (15) N2 ]-TBE-31) as an internal standard for quantification by stable isotope dilution LC-MS methodSuqing Zheng, Jeffrey T-J Huang, Elena V Knatko, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal TumorsYing Zhang, Elena V Knatko, Maureen Higgins, et al.
Cell Cycle (Georgetown, Tex.)|April 15, 2011
Mechanism-specific signatures for small-molecule p53 activatorsIngeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Enzyme Inhibition and Medicinal Chemistry|April 2, 2016
Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1Mostafa M Ghorab, Mansour S Alsaid, Marwa G El-Gazzar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 23, 2016
NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 4-aminoquinazoline derivativesMostafa M Ghorab, Mansour S Alsaid, Marwa G El-Gazzar, et al.
Scientific Reports|August 13, 2025
A fluorescence lifetime-based FLIM-timer for measuring the protein turnover of transcription factor Nrf2 in live cellsDina Dikovskaya, Claudia Bento-Pereira, Kanade Shiga, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 8, 2016
Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivativesMostafa M Ghorab, Mansour S Alsaid, Maureen Higgins, et al.
Ebiomedicine|May 17, 2021
Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinomaKevin Roth, Louis Coussement, Elena V Knatko, et al.
Drug Design, Development and Therapy|August 20, 2016
NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivativesMostafa M Ghorab, Mansour S Alsaid, Maureen Higgins, et al.
Molecular Cancer Therapeutics|February 19, 2013
Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 9, 2014
Synthesis of (13) C2 (15) N2 -labeled anti-inflammatory and cytoprotective tricyclic bis(cyanoenone) ([(13) C2 (15) N2 ]-TBE-31) as an internal standard for quantification by stable isotope dilution LC-MS methodSuqing Zheng, Jeffrey T-J Huang, Elena V Knatko, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal TumorsYing Zhang, Elena V Knatko, Maureen Higgins, et al.
Cell Cycle (Georgetown, Tex.)|April 15, 2011
Mechanism-specific signatures for small-molecule p53 activatorsIngeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, et al.
Pageof 6